Clinical Trials
13 trialsNCT00556907 2025-11-06
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
University of Southern California
Phase NA Terminated
NCT03535506 2025-09-26
WI223281
Georgetown University
Phase 2 Terminated
NCT02876640 2024-06-18
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT02127073 2023-11-09
Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
Montefiore Medical Center
Phase 2 Terminated
NCT02137252 2021-11-16
Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT00110136 2021-09-29
St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01060345 2020-04-09
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
University of Chicago
Phase 2 Terminated
NCT03505372 2020-02-11
Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia
Dana-Farber Cancer Institute
Phase NA Terminated
NCT02365714 2018-04-13
CK-SAPBI
Georgetown University
Phase 1/2 Terminated
NCT00290654 2017-12-28
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT01372618 2017-12-27
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
NYU Langone Health
Phase 1/2 Terminated
NCT01754519 2017-07-07
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00857714 2015-07-08
Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast
Indiana University
Phase NA Terminated